Spiramycin
Kathryn Dzintars, Pharm.D., BCPS, Paul G. Auwaerter, M.D.
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
- Spiramycin: not commercially available in the U.S.
- May be obtained as below (see Adult Dosing)
- Indicated for treating primary toxoplasmosis in pregnant women to prevent congenital toxoplasmosis (IgM titer needs to be confirmed by Dr. Jack S. Remington Laboratory for Specialty Diagnostics; T: 650-853-4828).
NON-FDA APPROVED USES
NON-FDA APPROVED USES
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved